CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Therapeutics
  • Top Emerging Therapeutics Companies

Therapeutics Special-2022 2022

Top 10 Emerging Therapeutics Companies – 2022

Top 10 Emerging Therapeutics Companies – 2022

Digital Therapeutics (DTx) have emerged in the last few years in a broad range of interventions to prevent, detect, manage or treat diseases (mental health, cognition, obesity, diabetes, heart disease, respiratory and many others), sometimes in combination with pharmaceutical products or medical devices (e.g., blood pressure cuffs).

Importantly, in these times of social distancing, several trends have emerged in how companies are creating DTx to help people with chronic conditions to live healthier in numerous ways. All DTx products provide active therapies to patients in the comfort of their own homes, and many allow their users to understand and manage their condition themselves. Many companies provide unique services and discretion regarding mental health, sleep problems and depression.

Digital therapeutics industry is focusing on developing high quality of healthcare products using advanced technology. During the outbreak of Covid-19, FDA generated guidelines, stating permission for the distribution, supply and use of digital therapeutic devices for the treatment of various disorders. This created an opportunity and led to increase in demand for the therapeutic devices across the world. Due to incidence of the coronavirus, this created awareness and alertness regarding importance of health management using digital therapeutic products.

Digital therapeutics helps to deliver medical therapies or treatments directly to the patients using scientific reports, clinically evaluated software used to treat patients, their management and used for the prevention of chronic diseases or disorders. Digital therapeutics products have the same set of standards and regulations as that of traditional medicinal products and treatments. Digital therapeutics must follow some of the core values like product safety, patient centricity, privacy, quality, and ongoing clinical trials impact on the product.

Further, based on sales channel, in caregiver channel accounted for largest share of digital therapeutics market and providers segment is expected to grow with highest CAGR in coming years. Geographically, North America dominated the digital therapeutics market in year 2020 and it is expected to expand more during the forecast period. Presence of advanced technology, developed healthcare infrastructure, and rising chronic diseases surge the demand for digital therapeutics market.

Let us know your thoughts.

Top 10 Emerging Therapeutics Companies – 2022

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Emerging Therapeutics Companies

    ★Featured Companies
    EMulate Therapeutics
    EMulate Therapeutics
    Read full profile →
    EMulate Therapeutics is a clinical-stage therapeutic device company utilizing its patented proprietary radio frequency energy (RFE) technology, targeted at the low and ultra-low ends of the RFE spectrum (ulRFE), to provide safe and effective therapeutic treatments for numerous unmet medical needs ... read full profile
    AyuVis Research
    AyuVis Research
    AyuVis was founded to find a solution to the problem of antibiotic resistance to drugs and to target the unmet clinical needs in life-threatening indications. Its lead program started in the immunomodulatory space to treat bacterial-induced hospital-based complicated Intra-Abdominal Infections (cIAI)
    CaraVan Biologix
    CaraVan Biologix
    CaraVan Biologix is focused on creating benefits for broad patient populations by addressing the limitations of whole cell chimeric receptor therapeutics. Its novel and intellectually protected technology platforms allow them to develop allogenic treatments for various human diseases
    Cend Therapeutics
    Cend Therapeutics
    Cend Therapeutics is a clinical-stage biotech company focused on a novel approach to enhance and more selectively deliver treatments to address a range of solid tumor cancers. The lead compound, CEND-1 (scientifically also known as iRGD), is a highly innovative molecular mimicry agent that is able to activate a drug transport mechanism specifically in solid tumors
    Incyclix Bio
    Incyclix Bio
    Incyclix Bio is a next-generation cell cycle control company, advancing precision treatments that target the aberrant proliferation driving many cancers. The company’s lead compound is a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor nearing clinical stage
    Kedalion Therapeutics
    Kedalion Therapeutics
    Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration
    Nereid Therapeutics
    Nereid Therapeutics
    Nereid Therapeutics is discovering new disease treatments using proprietary state-of-the-art technologies for generating, visualizing, and measuring liquid-liquid phase separation and resulting biomolecular condensates. Nereid applies leading expertise in soft matter physics and cell biology to pioneer completely new ways to fight intractable diseases
    Osteal Therapeutics
    Osteal Therapeutics
    Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences. The company's therapeutics offers a drug-device combination product to treat orthopedic infections, infected joint prosthesis
    Tiaki Therapeutics
    Tiaki Therapeutics
    Tiaki Therapeutics is developing first-in-class therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function. The company has developed a proprietary systems biology platform that preserves the complex biological interactions of brain cells and models the specific transcriptomic signature of neuroinflammation in dementia patients
    Virios Therapeutics
    Virios Therapeutics
    Virios Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM). The company is led by an executive team highly experienced in the successful development of therapies for FM

Therapeutics Info

Q1
What Do Top Therapeutics Companies Do?
Top Therapeutics Companies develop, test and advance treatments that address diseases through medicines, biologics, cell therapies, gene-based approaches and other therapeutic solutions. Their work spans discovery, clinical research, regulatory planning and patient access. In a listing context, therapeutics companies are evaluated not only by scientific promise, but also by the strength of their pipeline, evidence quality, disease focus and ability to move from research into real-world care.
Q2
Why Do Top Therapeutics Companies Matter Now?
Top Therapeutics Companies matter because healthcare is moving toward more targeted treatment models. Chronic disease, rare disorders, oncology, immunology and neurological conditions continue to create demand for therapies that improve outcomes beyond symptom control. Decision-makers are looking closely at therapeutics providers that can combine scientific depth with clinical discipline, regulatory readiness and patient relevance. The value lies in translating complex biology into treatments that are safer, more precise and more accessible.
Q3
How Should Decision-Makers Evaluate Therapeutics Companies?
Evaluation should begin with the company’s therapeutic focus, clinical-stage progress, scientific rationale and evidence base. Strong therapeutics companies usually show clarity in disease selection, trial design, regulatory pathway and commercialization readiness. Decision-makers should also consider leadership depth, manufacturing capability, partnerships, safety data and the company’s ability to address unmet medical needs. A broad pipeline is useful, but a focused and credible development strategy often matters more than volume.
Q4
What Value Do Top Therapeutics Companies Create?
Top Therapeutics Companies create value by improving treatment options for patients, physicians, healthcare systems and life sciences partners. Their impact may include better disease control, fewer side effects, improved adherence, reduced care burden or new options for conditions with limited therapies. For investors and partners, value also comes from pipeline resilience, differentiated science and scalable development models. The strongest therapeutic solutions connect clinical need with measurable patient and market relevance.
Q5
What Role Does Innovation Play in Therapeutics?
Innovation in therapeutics is increasingly shaped by precision medicine, biomarkers, advanced biologics, AI-supported discovery, regenerative medicine and new delivery platforms. Technology alone does not determine success. Its role becomes meaningful when it improves patient selection, trial efficiency, safety monitoring or treatment response. Leading therapeutics providers balance scientific ambition with clinical proof, regulatory discipline and ethical responsibility. That balance separates credible innovation from early-stage promise.
Q6
What Should Readers Prioritize When Comparing Therapeutics Companies?
Readers comparing Top Therapeutics Companies should prioritize evidence, focus and execution quality. A strong company should show a clear link between disease need, scientific mechanism, clinical progress and patient benefit. It should also demonstrate regulatory awareness, credible leadership, funding discipline and a realistic path to access. The best comparison is not based on visibility alone, but on whether the company can turn therapeutic science into dependable healthcare value.
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://therapeutics.lifesciencesreview.com/vendors/top-emerging-therapeutics-companies-2022.html